Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

OREXIN

Stay alert, don’t get hurt

An Author Correction to this article was published on 11 May 2018

This article has been updated

Both nucleus accumbens and orexin play clear roles in motivated behavior, but the functions of orexin projections to accumbens are poorly understood. Blomeley et al. show that this pathway, via specific orexin excitation of dopamine D2 receptor–expressing neurons, can inhibit reward seeking and exploratory drive when danger is perceived.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: An orexinergic input to nucleus accumbens that promotes risk avoidance.

Change history

  • 11 May 2018

    In the version of this article initially published, paragraph 8 mentioned intra-accumbens administration of SB334867. This should have read systemic (intraperitoneal) administration. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Blomeley, C., Garau, C. & Burdakov, D. Nat. Neurosci. https://doi.org/10.1038/s41593-017-0023-y (2017).

  2. Mahler, S. V., Moorman, D. E., Smith, R. J., James, M. H. & Aston-Jones, G. Nat. Neurosci. 17, 1298–1303 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Nelson, A. B. & Kreitzer, A. C. Annu. Rev. Neurosci. 37, 117–135 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Tepper, J. M. & Bolam, J. P. Curr. Opin. Neurobiol. 14, 685–692 (2004).

    Article  PubMed  CAS  Google Scholar 

  5. Baldo, B. A., Daniel, R. A., Berridge, C. W. & Kelley, A. E. J. Comp. Neurol. 464, 220–237 (2003).

    Article  PubMed  Google Scholar 

  6. Trivedi, P., Yu, H., MacNeil, D. J., Van der Ploeg, L. H. & Guan, X. M. FEBS Lett. 438, 71–75 (1998).

    Article  PubMed  CAS  Google Scholar 

  7. Castro, D. C., Terry, R. A. & Berridge, K. C. Neuropsychopharmacology 41, 2101–2111 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Haghparast, A. et al. Prog. Brain Res. 235, 139–154 (2017).

    Article  PubMed  Google Scholar 

  9. Mori, K., Kim, J. & Sasaki, K. Peptides 32, 246–252 (2011).

    Article  PubMed  CAS  Google Scholar 

  10. Bertran-Gonzalez, J. et al. J. Neurosci. 28, 5671–5685 (2008).

    Article  PubMed  CAS  Google Scholar 

  11. Yoshida, Y. et al. Eur. J. Neurosci. 14, 1075–1081 (2001).

    Article  PubMed  CAS  Google Scholar 

  12. Chou, T. C. et al. J. Neurosci 21, RC168 (2001).

    Article  PubMed  CAS  Google Scholar 

  13. Nestler, E. J. & Carlezon, W. A. Jr. Biol. Psychiatry 59, 1151–1159 (2006).

    Article  PubMed  CAS  Google Scholar 

  14. Tejeda, H. A. et al. Neuron 93, 147–163 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Muschamp, J. W. et al. Proc. Natl. Acad. Sci. USA 111, E1648–E1655 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen V. Mahler.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahler, S.V. Stay alert, don’t get hurt. Nat Neurosci 21, 3–5 (2018). https://doi.org/10.1038/s41593-017-0045-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41593-017-0045-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing